ALLIED HEALTHCARE PRODUCTS INC: restructuring charge — Allied Healthcare defaults, gets forbearance until Mar 27; retains 72 employees after WARN cuts

ALLIED HEALTHCARE PRODUCTS INC

Entered Ninth Amendment with Sterling Commercial Credit, increasing borrowing base to $2.5M, extending maturity to Sept 9, 2023.
Interest rate increased to prime + 6.5%; accounts receivable fee 0.6%; paid $50,000 amendment fee.
Acknowledged multiple defaults: material adverse effect from WARN notice, CEO/VP resignations (change of control), failure to engage stalking horse bidder by Feb 19.
Sterling granted forbearance until earlier of March 27, 2023 or new default; loan not accelerated.
Reduction in force: retained 72 employees (37 union); asserts $17.5M multiemployer pension withdrawal liability not triggered.

item 1.01 item 2.04 item 2.05 item 2.06 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

ALLIED HEALTHCARE PRODUCTS INC amended credit facility of $2,500,000.00 with Sterling Commercial Credit, LLC at 6.5% over the prime rate maturing September 9, 2023.

Instrument: credit facility
Principal: $2,500,000.00
Counterparty: Sterling Commercial Credit, LLC
Rate: 6.5% over the prime rate
Maturity: September 9, 2023
Event: amendment

Exact text from the filing

to the Credit Agreement with Sterling. The 9 th Amendment amends the Credit Agreement as follows: - The maximum availability under the Credit Agreement has been increased to $2,500,000.00 and the Company may now include inventory in the borrowing base; - The interest rate on outstanding amounts was amended to 6.5% over the prime rate, as defined in the Credit

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

ALLIED HEALTHCARE PRODUCTS INC amended Ninth Amendment to Loan and Security Agreement with Sterling Commercial Credit, LLC valued at Maximum availability increased to $2,500,000; interest rate amended to 6.5% over prime; accounts rec (effective 2023-03-14).

Action: amendment
Agreement: credit facility
Counterparty: Sterling Commercial Credit, LLC
Value: Maximum availability increased to $2,500,000; interest rate amended to 6.5% over prime; accounts rec
Effective: 2023-03-14

Exact text from the filing

On March 14, 2023, Summit Financial Resources, LLC ("Summit") sold and assigned its interest in the existing Loan and Security Agreement, dated February 27, 2017, by and between Summit and Allied Healthcare Products, Inc. (the "Company") as previously amended (the "Credit Agreement") to Sterling Commercial Credit, LLC ("Sterling"). Simultaneously with the assignment of the Credit Agreement from Summit to Sterling, the Company entered into a 9 th Amendment to the Credit Agreement with Sterling.

View on SEC.gov

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

ALLIED HEALTHCARE PRODUCTS INC announced a restructuring with charges of $17.5 million affecting St. Louis, Missouri manufacturing facilities and administrative offices (reduction in force that will impact employees of its St. Louis, Missouri manufacturing facilities and certain employees).

Type: restructuring
Charge: $17.5 million
Affected area: St. Louis, Missouri manufacturing facilities and administrative offices
Headcount: reduction in force that will impact employees of its St. Louis, Missouri manufacturing facilities and certain employees

Exact text from the filing

union employees, which would have triggered withdrawal liabilities owed to certain multiemployer pension plans which were most recently estimated by such pension plans to be $17.5 million. On March 16, 2023, the Company announced that its restructuring efforts have resulted in the retention of 72 employees at its St. Louis headquarters location, including 37 union

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001104659-23-033243

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.